HRTX Heron Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 10, 2026
$0.35
· % 处于52周区间
· 高于低点
· 至高点
$0.2652周低点
$1.5552周高点
市值
$65M
P/E (TTM)
-1.9
EPS (TTM)
$-0.18
收入 (TTM)
$151M
HRTX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.35
市值
$65M
P/E (TTM)
-1.9
EPS (TTM)
$-0.18
收入 (TTM)
$151M
ROE (TTM)
334.6%
52周区间
$0–$2
HRTX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2014年1月13日 | 1-for-20 | 反向 |
| 2007年5月25日 | 1-for-4 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$155M2016-12-31 → 2025-12-31
EPS$-0.122021-12-31 → 2025-12-31
自由现金流$-28M2016-12-31 → 2025-12-31
净利率-22.5%2016-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | HRTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -1.95年均值 ≈-7.1 | ≈-7.1 | · | · | |
| P/S | 0.45年均值 ≈3.8 | ≈3.8 | 186.1 | 低估 | |
| P/B (市净率) | 4.65年均值 ≈7.3 | ≈7.3 | 1.3 | 估值过高 | |
| Price / FCF (股价/自由现金流) | -2.35年均值 ≈-5.8 | ≈-5.8 | · | · | |
| Price / Cash Flow (市现率) | -2.45年均值 ≈-6.0 | ≈-6.0 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 4.65年均值 ≈17.0 | ≈17.0 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | HRTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 70.1%5年均值 ≈65.1% | ≈65.1% | · | · | |
| 营业利润率 (TTM) | -7.2%5年均值 ≈-102.2% | ≈-102.2% | -2571.0% | 顶尖 | |
| 息税折旧摊销前利润率 (TTM) | -5.8%5年均值 ≈-99.9% | ≈-99.9% | -2571.0% | 顶尖 | |
| 净利润率 (TTM) | -22.5%5年均值 ≈-106.8% | ≈-106.8% | -2615.5% | 顶尖 | |
| ROA (TTM) | -14.1%5年均值 ≈-38.7% | ≈-38.7% | -82.2% | 顶尖 | |
| ROE (TTM) | 334.6%5年均值 ≈-105.6% | ≈-105.6% | -72.9% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | HRTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 2.55年均值 ≈2.6 | ≈2.6 | 3.9 | 低流动性 | |
| Quick Ratio (速动比率) | 1.25年均值 ≈1.2 | ≈1.2 | 3.2 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | HRTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 7.4%5年均值 ≈12.2% | ≈12.2% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 12.9%5年均值 ≈14.8% | ≈14.8% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 11.8% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | HRTX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.65年均值 ≈0.5 | ≈0.5 | 0.0 | 顶尖 | |
| Inventory Turnover (库存周转率) | 0.65年均值 ≈1.0 | ≈1.0 | · | · | |
| Receivables Turnover (应收账款周转率) | 1.85年均值 ≈2.2 | ≈2.2 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$1.2M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-162.2%
下次报告
十一月 02, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 11, 2026 | $-0.03 | $0.01 | -394.1% |
| 2026年3月31日 | $-0.04 | $-0.02 | -161.4% | |
| 2025年12月31日 | $-0.02 | $-0.02 | 2.0% | |
| 2025年9月30日 | $-0.04 | $-0.02 | -161.4% | |
| 2025年6月30日 | $-0.02 | $-0.01 | -96.1% | |
| 2025年3月31日 | $0.01 | $-0.01 | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Cost of Revenue | $41M | $39M | $65M | $55M | $46M | $36M | $62M | $28M | $5M | $35.0K | |
| Gross Profit | $114M | $106M | $62M | $53M | · | · | · | · | · | · | |
| R&D Expense | $12M | $17M | $39M | $83M | $131M | $175M | $167M | $140M | $139M | $103M | |
| SG&A Expense | $55M | $53M | $66M | $62M | $40M | $42M | $38M | $29M | $26M | $21M | |
| Operating Expenses | $116M | $117M | $173M | $227M | $304M | $317M | $357M | $261M | $225M | $172M | |
| Operating Income | $-3M | $-12M | $-111M | $-175M | $-218M | $-228M | $-211M | $-184M | $-195M | $-171M | |
| Interest Expense | · | · | $4M | $2M | $2M | $2M | $1M | $3M | $4M | $3M | |
| Interest Income | $2M | $4M | $3M | $2M | $433.0K | $4M | $7M | $6M | $1M | $445.0K | |
| Other Non-op | $1M | $430.0K | $560.0K | $-7M | $-878.0K | $-847.0K | $158.0K | $2M | $-38.0K | $-9.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| EPS (Basic) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| EPS (Diluted) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| Shares (Basic) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| Shares (Diluted) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| EBITDA | $-224.0K | $-9M | $-108M | $-172M | $-215M | $-225M | $-209M | $-182M | $-193M | $-171M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $26M | $29M | $15M | $91M | $105M | $72M | $32M | $145M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | $301M | $28M | $38M | |
| Receivables | $90M | $79M | $60M | $52M | $35M | $42M | $40M | $65M | $42M | $2M | |
| Inventory | $93M | $53M | $42M | $55M | $48M | $42M | $25M | $39M | $10M | $5M | |
| Prepaid Expense | $9M | $18M | $6M | $14M | $13M | $22M | $23M | $11M | $4M | $4M | |
| Current Assets | $238M | $209M | $189M | $205M | $254M | $314M | $479M | $447M | $228M | $62M | |
| PP&E (Net) | $12M | $15M | $20M | $22M | $24M | $23M | $20M | $15M | $6M | $5M | |
| PP&E (Gross) | $25M | $33M | $37M | $36M | $37M | $34M | $28M | $23M | $14M | $12M | |
| Accum. Depreciation | $13M | $18M | $17M | $14M | $13M | $11M | $8M | $8M | $8M | $7M | |
| Other Non-current Assets | $5M | $6M | $8M | $16M | $18M | $346.0K | $346.0K | $254.0K | $263.0K | $263.0K | |
| Total Assets | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Accounts Payable | $9M | $12M | $3M | $3M | $4M | $525.0K | $3M | $17M | $19M | $7M | |
| Current Liabilities | $96M | $91M | $80M | $82M | $71M | $103M | $97M | $92M | $103M | $39M | |
| Capital Leases | $0 | · | $3M | $5M | $8M | $15M | $12M | · | · | · | |
| Other Non-current Liabilities | $5M | $615.0K | $241.0K | $241.0K | · | · | · | · | · | · | |
| Total Liabilities | $242M | $267M | $256M | $237M | $228M | $117M | $109M | $92M | $103M | $89M | |
| Common Stock | $2M | $2M | $2M | $1M | $1M | $913.0K | $903.0K | $782.0K | $646.0K | $394.0K | |
| Paid-in Capital | $1.95B | $1.88B | $1.87B | $1.81B | $1.69B | $1.63B | $1.57B | $1.33B | $914M | $564M | |
| Retained Earnings | $-1.94B | $-1.92B | $-1.91B | $-1.80B | $-1.61B | $-1.39B | $-1.17B | $-961M | $-783M | $-586M | |
| AOCI | $4.0K | $13.0K | $13.0K | $-19.0K | $-6.0K | $257.0K | $85.0K | $-87.0K | $-10.0K | $-17.0K | |
| Stockholders' Equity | $14M | $-34M | $-34M | $14M | $78M | $236M | $404M | $370M | $131M | $-21M | |
| Liabilities + Equity | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Shares Outstanding | 188,314,430 | 152,127,878 | 150,285,044 | 119,154,538 | 102,005,000 | 91,310,000 | 90,304,000 | 78,174,000 | 64,609,000 | 39,355 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $10M | $13M | $33M | $43M | $47M | $50M | $51M | $33M | $31M | $26M | |
| Restructuring | · | · | · | · | · | $6M | · | · | · | · | |
| Other Non-cash | $-20M | $-24M | $16M | $-11M | $-33M | $-11M | $27M | $-48M | $-5M | · | |
| Operating Cash Flow | $-28M | $-23M | $-59M | $-147M | $-203M | $-185M | $-125M | $-192M | $-170M | $-134M | |
| CapEx | $317.0K | $2M | $2M | $2M | $3M | $7M | $7M | $9M | $3M | $3M | |
| Investing Cash Flow | $16M | $19M | $18M | $-3M | $33M | $209M | $-22M | $-279M | $8M | $15M | |
| Net Debt Issued | · | · | · | · | · | · | · | $-25M | $-25M | · | |
| Stock Issued | $18M | · | $30M | $75M | · | · | $162M | $363M | $306M | · | |
| Net Stock Activity | $18M | · | $30M | $75M | · | · | $162M | · | · | · | |
| Financing Cash Flow | $14M | $940.0K | $54M | $75M | $156M | $9M | $186M | $358M | $294M | $57M | |
| Net Change in Cash | $3M | $-3M | $13M | $-75M | $-15M | $33M | $40M | $-113M | $131M | $-62M | |
| Free Cash Flow | $-28M | $-24M | $-60M | $-149M | $-206M | $-192M | $-132M | $-201M | $-173M | $-137M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.3% | 73.2% | 48.8% | · | · | · | · | · | · | · | |
| Operating Margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% | -257.4% | -144.3% | -237.4% | -632.4% | -13363.2% | |
| Net Margin | -13.0% | -9.4% | -87.0% | -169.0% | -255.6% | -256.4% | -140.3% | -230.8% | -641.9% | -13537.4% | |
| EBITDA Margin | -0.14% | -6.3% | -84.8% | -159.5% | -248.8% | -254.2% | -142.9% | -235.5% | -627.4% | -13363.2% | |
| ROA | -8.3% | -6.0% | -46.7% | -65.4% | -67.0% | -52.5% | -42.0% | -51.3% | -130.9% | -168.7% | |
| ROE | 312.5% | 36.9% | 358.0% | -1010.6% | -224.7% | -88.5% | -59.4% | -46.0% | -359.4% | -357.5% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 | 3.1 | 5.0 | 4.9 | 2.2 | 1.6 | |
| Quick Ratio | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 | 1.4 | 1.2 | 4.3 | 2.1 | 1.4 | |
| Interest Coverage | · | · | -28.6 | -70.6 | -90.4 | -120.0 | -143.1 | -68.8 | -49.4 | -64.2 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.0 | |
| Inventory Turnover | 0.6 | 0.8 | 1.3 | 1.1 | 1.0 | 1.1 | 1.9 | 1.1 | 0.6 | 0.0 | |
| Receivables Turnover | 1.8 | 2.1 | 2.3 | 2.5 | 2.2 | 2.2 | 2.8 | 1.5 | 1.4 | 1.3 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.08 | $-0.22 | $-0.23 | $0.11 | $0.76 | $2.59 | $4.47 | $4.74 | $2029.69 | $-0.54 | |
| Revenue / Share | $0.93 | $0.95 | $0.92 | $988.94 | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.17 | $-0.15 | $-0.43 | $-1349.35 | · | · | · | · | · | · | |
| Cash / Share | $0.15 | $0.17 | $0.19 | $0.13 | $0.89 | $1.15 | $0.80 | $0.41 | $2237.82 | $0.34 | |
| EPS (TTM) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.4% | 13.6% | 18.0% | 24.7% | -2.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.9% | 18.7% | 12.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Net Income TTM | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| Market Cap | $245M | $233M | $255M | $298M | $931M | $1.93B | $2.12B | $2.03B | $1M | $516M | |
| P/E | -10.8 | -17.0 | -2.1 | -1.5 | -4.1 | · | · | · | · | · | |
| P/S | 1.6 | 1.6 | 2.0 | 2.8 | 10.8 | 21.8 | 14.5 | 26.2 | 0.0 | 403.1 | |
| P/B | 17.1 | -6.9 | -7.5 | 21.9 | 12.0 | 8.2 | 5.3 | 5.5 | 0.0 | -24.3 | |
| P / Tangible Book | 17.1 | · | · | 21.9 | 12.0 | 8.2 | · | · | · | · | |
| P / Cash Flow | -8.9 | -10.3 | -4.3 | -2.0 | -4.6 | -10.5 | -17.0 | -10.6 | -0.0 | -3.8 | |
| P / FCF | -8.8 | -9.6 | -4.2 | -2.0 | -4.5 | -10.1 | -16.1 | -10.1 | -0.0 | -3.8 | |
| Earnings Yield | -9.2% | -5.9% | -47.1% | -66.8% | -24.5% | · | · | · | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38M | $35M | $41M | $38M | $37M | $39M | $41M | $33M | $36M | $35M | $34M | $31M | $32M | $30M | $30M | $27M | |
| Cost of Revenue | $12M | $11M | $11M | $12M | $10M | $8M | $10M | $9M | $11M | $8M | $10M | $18M | $20M | $17M | $13M | $15M | |
| Gross Profit | $26M | $24M | $29M | $26M | $27M | $30M | $31M | $23M | $26M | $26M | $24M | $13M | $12M | $13M | $17M | $12M | |
| R&D Expense | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $4M | $5M | $8M | $9M | $13M | $9M | $-14M | $26M | |
| SG&A Expense | $11M | $12M | $13M | $14M | $14M | $13M | $12M | $12M | $14M | $15M | $14M | $16M | $20M | $16M | $34M | $10M | |
| Operating Expenses | $28M | $29M | $29M | $30M | $29M | $27M | $26M | $28M | $32M | $31M | $35M | $38M | $54M | $46M | $10M | $54M | |
| Operating Income | $-2M | $-5M | $38.0K | $-4M | $-2M | $3M | $4M | $-4M | $-6M | $-5M | $-10M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| Other Non-op | $-3M | $-3M | $5M | $-2M | $-744.0K | $-519.0K | $2M | $-390.0K | $-3M | $2M | $0 | $-79.0K | $344.0K | $295.0K | $1M | $-26.0K | |
| Net Income | $-5M | $-8M | $-3M | $-17M | $-2M | $3M | $4M | $-5M | $-9M | $-3M | $-11M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| EPS (Basic) | $-0.03 | $-0.04 | $-0.02 | $-0.10 | $-0.02 | $0.02 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| EPS (Diluted) | $-0.03 | $-0.04 | $-0.01 | $-0.10 | $-0.02 | $0.01 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| Shares (Basic) | 190,335,000 | 189,646,000 | · | 170,348,000 | 154,020,000 | 153,490,000 | · | 152,830,000 | 152,305,000 | 151,199,000 | · | 144,990,000 | 119,719,000 | 119,246,000 | · | 111,735,000 | |
| Shares (Diluted) | 190,335,000 | 189,646,000 | · | 170,348,000 | 154,020,000 | 196,921,000 | · | 152,830,000 | 152,305,000 | 151,199,000 | · | 144,990,000 | 119,719,000 | 119,246,000 | · | 111,735,000 | |
| EBITDA | $-2M | $-4M | · | $-4M | $-2M | $4M | · | $-4M | $-6M | $-4M | · | $-25M | $-42M | $-32M | · | $-42M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $26M | $29M | $43M | $17M | $19M | $26M | $26M | $18M | $20M | · | $35M | $13M | $27M | · | $50M | |
| Receivables | $90M | $84M | $90M | $81M | $80M | $79M | $79M | $67M | $74M | $65M | · | $64M | $77M | $51M | · | $42M | |
| Inventory | $91M | $93M | $93M | $70M | $73M | $57M | $53M | $46M | $43M | $42M | · | $42M | $45M | $52M | · | $52M | |
| Prepaid Expense | $7M | $8M | $9M | $23M | $17M | $26M | $18M | $11M | $7M | $7M | · | $11M | $11M | $15M | · | $8M | |
| Current Assets | $230M | $229M | $238M | $229M | $211M | $213M | $209M | $195M | $191M | $186M | · | $194M | $165M | $178M | · | $224M | |
| PP&E (Net) | $12M | $12M | $12M | $13M | $14M | $15M | $15M | $15M | $16M | $19M | · | $21M | $21M | $22M | · | $23M | |
| PP&E (Gross) | · | · | $25M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $13M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $8M | · | $8M | $9M | $14M | · | $17M | |
| Total Assets | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Accounts Payable | $12M | $9M | $9M | $12M | $12M | $12M | $12M | $10M | $10M | $837.0K | · | $2M | $2M | $4M | · | $7M | |
| Current Liabilities | $92M | $91M | $96M | $90M | $259M | $89M | $91M | $86M | $80M | $75M | · | $80M | $87M | $78M | · | $94M | |
| Capital Leases | $6M | · | · | · | · | · | · | $522.0K | $1M | $2M | · | $4M | $4M | $5M | · | $6M | |
| Other Non-current Liabilities | $5M | $5M | $5M | $5M | $747.0K | $682.0K | $615.0K | $241.0K | $241.0K | $241.0K | · | $241.0K | $241.0K | $241.0K | · | $241.0K | |
| Total Liabilities | $245M | $237M | $242M | $234M | $259M | $264M | $267M | $261M | $256M | $252M | · | $257M | $241M | $232M | · | $250M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $1.96B | $1.95B | $1.95B | $1.94B | $1.89B | $1.89B | $1.88B | $1.88B | $1.88B | $1.87B | · | $1.87B | $1.83B | $1.82B | · | $1.80B | |
| Retained Earnings | $-1.95B | $-1.95B | $-1.94B | $-1.94B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.91B | · | $-1.90B | $-1.87B | $-1.83B | · | $-1.78B | |
| AOCI | $-6.0K | $-6.0K | $4.0K | $0 | $-1.0K | $1.0K | $13.0K | $40.0K | $-8.0K | $-6.0K | · | $-1.0K | $-6.0K | $9.0K | · | $-57.0K | |
| Stockholders' Equity | $7M | $9M | $14M | $15M | $-27M | $-28M | $-34M | $-40M | $-38M | $-34M | $-34M | $-28M | $-39M | $-11M | $14M | $22M | |
| Liabilities + Equity | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Shares Outstanding | · | · | 188,314,430 | · | · | · | 152,127,878 | · | · | · | · | · | · | · | · | · |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $452.0K | $529.0K | $537.0K | $615.0K | $611.0K | $551.0K | $581.0K | $581.0K | $641.0K | $689.0K | $715.0K | $727.0K | $739.0K | $718.0K | $791.0K | $706.0K | |
| Stock-based Comp | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $5M | $3M | $4M | $7M | $14M | $8M | $11M | $11M | |
| Other Non-cash | · | $3M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-797.0K | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-9M | $1M | $-11M | $-9M | $-12M | $3M | $-5M | $-10M | $2M | $-9M | $-27M | $-25M | $-38M | $-37M | |
| CapEx | $138.0K | $391.0K | $0 | $0 | $208.0K | $109.0K | $638.0K | $431.0K | · | · | $250.0K | $793.0K | $278.0K | $224.0K | $414.0K | $45.0K | |
| Investing Cash Flow | $-3M | $-939.0K | $-5M | $12M | $7M | $2M | $11M | $4M | $2M | $1M | $-9M | $-23M | $13M | $37M | $2M | $-36M | |
| Stock Issued | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $82.0K | $-51.0K | $219.0K | $13M | $781.0K | $64.0K | $423.0K | $14.0K | $492.0K | $11.0K | $199.0K | $54M | $319.0K | $-208.0K | $439.0K | $75M | |
| Net Change in Cash | $-5M | $-3M | $-14M | $27M | $-3M | $-7M | $61.0K | $7M | $-2M | $-8M | $-6M | $21M | $-14M | $12M | $-35M | $2M | |
| Free Cash Flow | · | $-2M | · | · | · | $-9M | · | · | · | · | · | · | · | $-25M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.3% | 69.3% | · | 68.8% | 73.5% | 78.3% | · | 71.2% | 70.8% | 75.6% | · | 42.1% | · | · | · | · | |
| Operating Margin | -5.4% | -13.7% | · | -10.7% | -4.4% | 8.1% | · | -13.6% | -17.9% | -13.8% | · | -79.3% | -133.5% | -111.6% | · | -157.7% | |
| Net Margin | -14.6% | -23.4% | · | -45.8% | -6.4% | 6.8% | · | -14.8% | -25.6% | -9.1% | · | -79.6% | -132.4% | -110.7% | · | -157.8% | |
| EBITDA Margin | -5.4% | -12.2% | · | -10.7% | -4.4% | 9.5% | · | -13.6% | -17.9% | -11.8% | · | -79.3% | -133.5% | -109.2% | · | -157.7% | |
| ROA | -2.3% | -3.4% | · | -7.4% | -1.1% | 1.2% | · | -2.1% | -4.4% | -1.4% | · | -10.0% | -18.9% | -13.2% | · | -13.4% | |
| ROE | 53.9% | 84.0% | · | 139.3% | 7.3% | -8.5% | · | 14.3% | 23.9% | 14.0% | · | 937.3% | 137.8% | -523.1% | · | -59.3% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.5 | · | 2.6 | 0.8 | 2.4 | · | 2.3 | 2.4 | 2.5 | · | 2.4 | 1.9 | 2.3 | · | 2.4 | |
| Quick Ratio | 1.2 | 1.2 | · | 1.4 | 0.4 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | 1.0 | 1.0 | · | 1.0 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.3 | · | 0.3 | |
| Receivables Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.20 | $0.18 | · | $0.22 | $0.24 | $0.20 | · | $0.21 | $0.24 | $0.23 | · | $0.22 | $0.27 | $0.25 | · | $0.24 | |
| Cash Flow / Share | · | $-0.01 | · | · | · | $-0.04 | · | · | · | $-0.06 | · | · | · | $-0.21 | · | · | |
| EPS (TTM) | $-0.18 | $-0.17 | · | $-0.09 | $-0.02 | $-0.06 | · | $-0.12 | $-0.26 | $-0.55 | · | $-0.90 | $-1.11 | $-1.31 | · | $-2.09 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $151M | $151M | · | $155M | $150M | $149M | · | $138M | $136M | $132M | · | $123M | $118M | $114M | · | $98M | |
| Net Income TTM | $-34M | $-31M | · | $-14M | $-931.0K | $-8M | · | $-28M | $-48M | $-81M | · | $-120M | $-137M | $-151M | · | $-217M | |
| P/E | -2.4 | -4.7 | · | -14.0 | -103.5 | -36.7 | · | -16.6 | -13.5 | -5.0 | · | -1.1 | -1.0 | -1.2 | · | -2.0 | |
| Earnings Yield | -41.9% | -21.2% | · | -7.1% | -0.97% | -2.7% | · | -6.0% | -7.4% | -19.9% | · | -87.4% | -95.7% | -86.8% | · | -49.5% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $155M | $144M | $127M | $108M | $86M |
| 毛利率 % | 73.3% | 73.2% | 48.8% | · | · |
| 营业利润率 % | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% |
| 净收入 | $-20M | $-14M | $-111M | $-182M | $-221M |
| 稀释后每股收益 (EPS) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 |
| 速动比率 | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-28M | $-24M | $-60M | $-149M | $-206M |
机构持有人 (13F) 182 家申报者 · $72.8M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
182
持有价值
$72.8M
新仓位
22
已退出持仓
21
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 22 (-15 与上一季度对比) | 21 (-6 与上一季度对比) | 58 (+7 与上一季度对比) | 42 (-2 与上一季度对比) | -23.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Rubric Capital Management LP | $12823986 | 30046828 | 17.60% | 股份 |
| VANGUARD GROUP INC | $12766499 | 9820384 | 17.53% | 股份 |
| Clearline Capital LP | $4858675 | 11383961 | 6.67% | 股份 |
| BlackRock, Inc. | $4503060 | 10550750 | 6.18% | 股份 |
| Velan Capital Investment Management LP | $3735904 | 8753290 | 5.13% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3323230 | 7782741 | 4.56% | 股份 |
| Tejara Capital Ltd | $2778807 | 6510795 | 3.81% | 股份 |
| TANG CAPITAL MANAGEMENT LLC | $2667500 | 6250000 | 3.66% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $1823405 | 4270980 | 2.50% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $1737119 | 4070101 | 2.38% | 股份 |
| JW Asset Management, LLC | $1600958 | 3751073 | 2.20% | 股份 |
| Stonepine Capital Management, LLC | $1500000 | 1000000 | 2.06% | 买入期权 |
| STATE STREET CORP | $1377948 | 3228557 | 1.89% | 股份 |
| UBS Group AG | $1279750 | 2997073 | 1.76% | 股份 |
| Pale Fire Capital SE | $1071899 | 2511478 | 1.47% | 股份 |
| MARSHALL WACE, LLP | $1012302 | 2354193 | 1.39% | 股份 |
| Caption Management, LLC | $896280 | 2100000 | 1.23% | 卖出期权 |
| Congress Park Capital LLC | $860620 | 2016447 | 1.18% | 股份 |
| Richmond Brothers, Inc. | $764961 | 1792319 | 1.05% | 股份 |
| TWO SIGMA ADVISERS, LP | $675442 | 519571 | 0.93% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $674878 | 1580510 | 0.93% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $663186 | 1553857 | 0.91% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $643145 | 1506900 | 0.88% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $582906 | 1365119 | 0.80% | 股份 |
| GOLDMAN SACHS GROUP INC | $567539 | 1329754 | 0.78% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $547071 | 1281796 | 0.75% | 股份 |
| NORTHERN TRUST CORP | $522181 | 1223480 | 0.72% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $519613 | 1217463 | 0.71% | 股份 |
| Qube Research & Technologies Ltd | $435802 | 1021092 | 0.60% | 股份 |
| Caption Management, LLC | $426800 | 1000000 | 0.59% | 股份 |
| CM Management, LLC | $426800 | 1000000 | 0.59% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $296270 | 694165 | 0.41% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $239958 | 299910 | 0.33% | 股份 |
| Stonepine Capital Management, LLC | $209468 | 490787 | 0.29% | 股份 |
| NEXPOINT ASSET MANAGEMENT, L.P. | $203050 | 475750 | 0.28% | 股份 |
| DIADEMA PARTNERS LP | $195783 | 458723 | 0.27% | 股份 |
| Invesco Ltd. | $173565 | 406668 | 0.24% | 股份 |
| Xcelsior Advisor Partners LLC | $173186 | 405777 | 0.24% | 股份 |
| Bank of New York Mellon Corp | $168944 | 395838 | 0.23% | 股份 |
| Apeiron RIA LLC | $158163 | 370579 | 0.22% | 股份 |
| Squarepoint Ops LLC | $137078 | 321177 | 0.19% | 股份 |
| Glenmede Investment Management, LP | $132710 | 105326 | 0.18% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $113663 | 266314 | 0.16% | 股份 |
| FMR LLC | $96800 | 226803 | 0.13% | 股份 |
| Nuveen, LLC | $94659 | 221787 | 0.13% | 股份 |
| Abel Hall, LLC | $90987 | 213185 | 0.12% | 股份 |
| CAROLINAS WEALTH CONSULTING LLC | $90983 | 41356 | 0.12% | 股份 |
| Horan Securities, Inc. | $86091 | 41590 | 0.12% | 股份 |
| RHUMBLINE ADVISERS | $83482 | 195537 | 0.11% | 股份 |
| Cutter & CO Brokerage, Inc. | $80223 | 36465 | 0.11% | 股份 |
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Rubric Capital Management LP, David Rosen ×6 申报 | 2025年10月17日 | 15.90% | 修订 | · | SEC |
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin Tang ×20 申报 | 2020年1月7日 | · | 初始申报 | · | SEC |
| Felix J. Baker, Julian C. Baker ×3 申报 | 2011年7月7日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 40 位内幕人士 · 21 位高管 · 21 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Craig A Collard | Chief Executive Officer | 2026年7月31日 M | 856492 | 0 | 0 | $0 |
| Barry D Quart | Chief Executive Officer | 2023年1月18日 A | 177989 | 0 | 0 | $0 |
| Ronald J Prentki | President & CEO | 2010年2月17日 A | 40539 | 0 | 0 | $0 |
| Michael Oconnell | Chief Executive Officer | 2006年1月10日 A | 132200 | 0 | 0 | $0 |
| Ira Duarte | EVP, Chief Financial Officer | 2026年7月31日 M | 281899 | 0 | 0 | $0 |
| Robert Hoffman | CFO & SVP, Finance | 2019年12月19日 A | 1280 | 0 | 0 | $0 |
| Brian G. Drazba | VP, Finance & CFO | 2016年10月31日 J | 3798 | 0 | 0 | $0 |
| John Whelan | CFO | 2013年7月18日 M | 254088 | 0 | 0 | $0 |
| Stephen Whiteford | V.P., Finance & CFO | 2006年12月15日 A | 15000 | 0 | 0 | $0 |
| John Poyhonen | President & CCO | 2023年4月13日 M | 46648 | 0 | 0 | $0 |
| Robert Rosen | President | 2018年12月15日 A | 2640 | 0 | 0 | $0 |
| David Leslie Szekeres | EVP, Chief Operating Officer | 2023年7月13日 M | 33754 | 0 | 0 | $0 |
| Michael A Adam | Chief Operating Officer | 2013年2月8日 A | · | 0 | 0 | $0 |
| William P Forbes | EVP, Chief Development Officer | 2026年7月31日 M | 241173 | 0 | 0 | $0 |
| Lisa Peraza | VP, Chief Accounting Officer | 2024年1月19日 A | 55907 | 0 | 0 | $0 |
| Kimberly Manhard | EVP, Drug Development | 2023年4月13日 M | 28330 | 0 | 0 | $0 |
| Marshall Paul | SVP, Technical Operations | 2016年3月21日 M | 2200 | 0 | 0 | $0 |
| Neil James Clendeninn | SVP & Chief Medical Officer | 2015年10月12日 A | · | 0 | 0 | $0 |
| Mark S. Gelder MD | SVP & Chief Medical Officer | 2014年12月12日 A | · | 0 | 0 | $0 |
| John Barr | Vice President of R&D | 2011年7月8日 A | 51772 | 0 | 0 | $0 |
| Anastassios D. Retzios | VP of Clinical Development | 2008年1月15日 A | · | 0 | 0 | $0 |
| Thomas Cusack | 董事 | 2026年1月30日 A | 53960 | 0 | 0 | $0 |
| Morgan Adam | 董事 | 2026年1月30日 A | 123737 | 0 | 0 | $0 |
| Sharmila Dissanaike | 董事 | 2026年1月30日 A | 53960 | 0 | 0 | $0 |
| Michael Kaseta | 董事 | 2026年1月30日 A | 53960 | 0 | 0 | $0 |
| Waage Christian | 董事 | 2026年1月30日 A | 53960 | 0 | 0 | $0 |
| Craig A Johnson | 董事 | 2026年1月30日 A | 53960 | 0 | 0 | $0 |
| Susan Rodriguez | 董事 | 2025年1月31日 A | 87180 | 0 | 0 | $0 |
| Stephen Davis | 董事 | 2022年12月16日 A | 52032 | 0 | 0 | $0 |
| KEVIN TANG | 董事 | 2019年12月19日 A | 5799810 | 0 | 0 | $0 |
| Greg Turnbull | 董事 | 2012年5月29日 A | 245092 | 0 | 0 | $0 |
| Paul Goddard | 董事 | 2012年5月29日 A | 214683 | 0 | 0 | $0 |
| Toby Rosenblatt | 董事 | 2010年5月20日 A | 210234 | 0 | 0 | $0 |
| Robert L Zerbe MD | 董事 | 2010年5月20日 A | 202072 | 0 | 0 | $0 |
| Peter Riepenhausen | 董事 | 2008年5月28日 A | 9000 | 0 | 0 | $0 |
| Arthur T Taylor | 董事 | 2008年5月28日 A | 12000 | 0 | 0 | $0 |
| Dennis L Winger | 董事 | 2006年8月11日 A | 69544 | 0 | 0 | $0 |
| Stephen A Drury | 董事 | 2006年8月11日 J | 83283 | 0 | 0 | $0 |
| SPCH, LLLP | 10% 所有者 | 2013年1月1日 J | 0 | 0 | 0 | $0 |
| Mark Earl Hensley | · | 2026年8月6日 M | 170901 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 15 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.51% | 376931 SH | 2026年10月1日 | 每日 |
| IWC · iShares Trust | 0.01% | 533800 SH | 2026年9月11日 | 每日 |
| IWO · iShares Trust | 0.00% | 1361330 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.00% | 76332 NS | 2026年7月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 199192 SH | 2026年9月30日 | 每日 |
| IWM · iShares Trust | 0.00% | 3617230 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 2063361 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 5474947 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 925988 SH | 2026年8月19日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 13208 SH | 2026年8月19日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 156616 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 12513 SH | 2026年8月19日 | 每日 |
| IWV · iShares Trust | 0.00% | 28936 SH | 2026年9月3日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.00% | 472185 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 507316 SH | 2026年9月11日 | 每日 |
HRTX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 7 位分析师
卖出
中位数目标
$7.00
+1913.8%
0 0.0%
强烈买入
0 0.0%
买入
4 57.1%
持有
1 14.3%
卖出
2 28.6%
强烈卖出
12个月价格目标
3 位分析师 · 2026-10-01平均目标 $7.00 +1913.8%
← 低于所有目标
当前价格 $0.35
最低$5.00
平均值$7.00
最高$9.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 10, 2026 申报